SMTL ID : 3kk6.1

Crystal Structure of Cyclooxygenase-1 in complex with celecoxib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

homo-dimer

Ligands

1 x NAG- NAG- MAN- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-MAN-BMA-MAN.1: 11 residues within 4Å: Chain A: E.109, N.113, S.115, Y.116, M.185, F.189 Chain B: L.207, E.208, Y.211, Q.212, P.239 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:Q.212, B:Q.212 Water bridges: B:K.222

3 x NAG- NDG: 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG-NDG.2: 9 residues within 4Å: Chain A: Q.369, Y.371, E.374, Q.375, N.379, S.381, M.382, D.385, Y.386 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.379, A:D.385, A:Q.369, A:Y.371, A:Q.375 Water bridges: A:Q.369, A:Q.369 NAG-NDG.3: 6 residues within 4Å: Chain B: P.4, Y.7, P.9, Y.24, P.36, N.37 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Y.24, B:N.37 Hydrophobic interactions: B:Y.7 NAG-NDG.5: 9 residues within 4Å: Chain B: Q.369, Y.371, E.374, Q.375, N.379, S.381, M.382, D.385, Y.386 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Y.371, B:N.379, B:D.385, B:D.385, B:Y.371

1 x NAG- NAG- MAN- BMA: beta-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-MAN-BMA.4: 9 residues within 4Å: Chain A: L.207, E.208, Y.211 Chain B: E.109, N.113, S.115, Y.116, M.185, F.189 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:M.185

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.6: 25 residues within 4Å: Chain A: Y.117, A.168, A.171, Q.172, T.175, H.176, F.179, K.180, T.181, L.264, N.351, Y.354, H.355, W.356, H.357, L.359, M.360, F.364, L.377, I.413, H.415, V.416, D.419, V.420 Ligands: FLC.10 14 PLIP interactions: 14 interactions with chain A, Hydrophobic interactions: A:A.171, A:Q.172, A:Q.172, A:F.179, A:L.264, A:W.356, A:I.413, A:V.416 Hydrogen bonds: A:Y.117, A:T.181, A:N.351, A:D.419 Water bridges: A:D.419 pi-Stacking: A:H.176 HEM.11: 25 residues within 4Å: Chain B: Y.117, A.168, A.171, Q.172, T.175, H.176, F.179, K.180, T.181, L.264, N.351, Y.354, H.355, W.356, H.357, L.359, M.360, F.364, Y.373, L.377, I.413, H.415, V.416, D.419, V.420 13 PLIP interactions: 13 interactions with chain B, Hydrophobic interactions: B:Q.172, B:T.175, B:F.179, B:F.179, B:L.264, B:Y.354, B:I.413, B:V.416 Hydrogen bonds: B:F.179, B:T.181, B:T.181 pi-Cation interactions: B:H.176, B:H.355

2 x CEL: 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE(Non-covalent)

CEL.7: 22 residues within 4Å: Chain A: H.59, V.85, Q.161, Y.317, V.318, L.321, S.322, Y.324, L.328, F.350, L.353, Y.354, W.356, S.485, I.486, F.487, M.491, I.492, G.495, A.496, S.499, L.500 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.321, A:L.321, A:Y.324, A:Y.324, A:W.356, A:F.487, A:I.492 Hydrogen bonds: A:Q.161, A:L.321, A:I.486, A:F.487 pi-Cation interactions: A:R.89 CEL.12: 21 residues within 4Å: Chain B: H.59, V.85, Q.161, V.318, L.321, S.322, Y.324, L.328, F.350, L.353, Y.354, W.356, S.485, I.486, F.487, M.491, I.492, G.495, A.496, S.499, L.500 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:V.318, B:L.321, B:L.321, B:Y.324, B:W.356, B:F.487, B:I.492, B:I.492 Hydrogen bonds: B:H.59, B:Q.161, B:L.321, B:I.486, B:F.487

4 x BOG: octyl beta-D-glucopyranoside(Non-covalent)(Post Translational Modification)

BOG.8: 14 residues within 4Å: Chain A: P.55, I.58, L.61, L.62, W.69, L.81, L.84, V.85, V.88, R.89, L.92, L.326, E.493, P.497 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.58, A:L.62, A:L.62, A:W.69, A:L.81, A:L.84, A:L.84, A:V.85 Hydrogen bonds: A:E.493, A:E.493 Salt bridges: A:R.89 BOG.9: 5 residues within 4Å: Chain A: P.53, S.54, S.56, F.57, F.60 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:P.53, A:F.57, A:F.57, A:F.57 Hydrogen bonds: A:S.54, A:S.54 BOG.13: 15 residues within 4Å: Chain B: R.52, P.55, I.58, L.62, L.81, L.84, V.85, V.88, R.89, L.92, F.439, G.440, M.441, E.493, P.497 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:I.58, B:L.84, B:L.84, B:V.85 Hydrogen bonds: B:R.52, B:R.89, B:E.493, B:E.493 Salt bridges: B:R.89 BOG.14: 3 residues within 4Å: Chain B: I.40, P.41, W.46 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:W.46

1 x FLC: CITRATE ANION(Non-covalent)

FLC.10: 6 residues within 4Å: Chain A: K.180, T.181, S.182, G.183, V.260 Ligands: HEM.6 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.181

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rimon, G. et al., Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc.Natl.Acad.Sci.USA (2010)

Release Date

2009-12-15

Peptides

Prostaglandin G/H synthase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Prostaglandin G/H synthase 1

Related Entries With Identical Sequence